跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBUPROFEN LIQUID GELS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IBUPROFEN LIQUID GELS
Authorized
STANDARD
IBUPROFEN LIQUID GELS
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c3f3e37b985db292
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
c3f3e37b985db292
Drug Approval Canada Name
IBUPROFEN LIQUID GELS
Product Name
IBUPROFEN LIQUID GELS
Status
Marketed
Status Date
2021-03-22
Original Market Date
2021-03-22
Din
02494353
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE01 IBUPROFEN
Atc Name
m 01 ae 01
Aig Number
0108883004
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
IBUPROFEN
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c3f3e37b985db292
Type
Standard
Back to Health Canada Approvals